AmerisourceBergen’s Strategic Relationship with Walgreens and Alliance Boots

On March 19, 2013, AmerisourceBergen Corporation announced that it is entering into a strategic, long‑term relationship with Walgreen Co. and Alliance Boots GmbH, which will streamline the distribution of pharmaceuticals to Walgreens stores and leverage global supply chain efficiencies while improving patient access to affordable pharmaceuticals to increase the efficiency of the healthcare system. Cravath represented AmerisourceBergen in this transaction.

AmerisourceBergen’s new expanded relationship with Walgreens and Alliance Boots includes: a ten‑year comprehensive primary pharmaceutical distribution contract with Walgreens; access to generic drugs and related pharmaceutical products through the Walgreens Boots Alliance Development joint venture; and opportunities to accelerate the Company’s efforts to grow its specialty and manufacturer services businesses domestically and internationally. In furtherance of this new partnership, Walgreens and Alliance Boots together have been granted rights to purchase an equity position in AmerisourceBergen.

The Cravath team included partner Robert I. Townsend III and associates Benjamin P. Schaye and Maya A. Rosenthal‑Larrea on corporate matters; partner Lauren Angelilli and associate Joanne J. Lee on tax matters; and partner Christine A. Varney, practice area attorneys Robin C. Landis and Thomas C. Viles and associates Veena Viswanatha and Athena N. Cheng on antitrust matters. Stephen R. Severo also worked on tax matters.